Figure 11
From: Recombinant anti-HIV MAP30, a ribosome inactivating protein: against plant virus and bacteriophage

Inoculation of C. quinoa seedlings in the two-time interval assays with purified CMV and rMAP30. There were 8 replicates for each test. (a,b) The primary incubation with rMAP30 for 6 h, then apply viral infection on the leaves surface (c,d). The primary incubation with viral infection for a 6 h, then apply rMAP30 on the leaves surface. It has been shown that the higher infection control observed when viral incubation has done 6 h prior than rMAP30. However, the control percentage in the initial treatment assay with rMAP30 is also significant and the number of viral spots is reduced.